Medicare Enrolled
Dr. Richard Redman, M.D.
Pulmonary Disease · Olympia, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Redman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Redman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Redman
Dr. Richard Redman is a pulmonary disease specialist in Olympia, WA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Redman performed 2,759 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Redman received a total of $131,653 from 19 pharmaceutical and/or device companies across 248 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Redman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 2% volume in WA
$131,653 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,759
Medicare services
Top 2% in WA for pulmonary disease
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
634 | $65 | $260 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
339 | $91 | $368 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
256 | $35 | $134 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
254 | $34 | $131 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
209 | $163 | $612 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
171 | $26 | $97 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
147 | $23 | $87 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
131 | $19 | $71 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
75 | $111 | $479 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
69 | $87 | $341 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
61 | $11 | $379 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
57 | $61 | $227 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
37 | $44 | $415 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
37 | $142 | $624 |
| Bronchoscopy A procedure to examine the airways inside the lungs using a thin, flexible tube with a camera. |
35 | $0 | $372 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
35 | $62 | $497 |
| Moderate sedation during GI endoscopy Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient. |
31 | $4 | $16 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
25 | $65 | $241 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
24 | $74 | $272 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
24 | $51 | $188 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
21 | $137 | $527 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $102 | $373 |
| Additional lung lobe biopsy via endoscope This procedure involves taking a tissue sample from an additional lobe of the lung using an endoscope. It is performed as an add-on service to a primary biopsy of a different lung lobe. |
18 | $48 | $178 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $133 | $498 |
| Placement of radiation therapy markers in lung airways A procedure where small markers are placed into the airways of the lung using an endoscope to assist with radiation therapy targeting. |
12 | $75 | $556 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
12 | $11 | $41 |
| New patient office visit, complex (60-74 min) | 11 | $158 | $632 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.9% high complexity
13.1% medium
86.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$131,653
Total received (2018-2024)
Avg $18,808/year across 7 years
Top 5% in WA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
248
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$297
2023
$350
2022
$4,188
2021
$4,290
2020
$30,325
2019
$46,407
2018
$45,795
Payments by company (2024)
GENZYME CORPORATION
$120
INTUITIVE SURGICAL, INC.
$86
GlaxoSmithKline, LLC.
$49
Resmed Corp
$22
Inspire Medical Systems, Inc.
$20
Top 3 companies account for 86.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$53,332
Boehringer Ingelheim Pharmaceuticals, Inc.
$44,016
Actelion Pharmaceuticals US, Inc.
$13,811
Intuitive Surgical, Inc.
$4,258
AstraZeneca Pharmaceuticals LP
$4,188
ViiV Healthcare Company
$3,400
Genentech USA, Inc.
$3,029
Bayer HealthCare Pharmaceuticals Inc.
$2,505
Gilead Sciences, Inc.
$1,799
Actelion Pharmaceuticals, Ltd
$757
GENZYME CORPORATION
$164
Regeneron Healthcare Solutions, Inc.
$113
SANOFI-AVENTIS U.S. LLC
$100
INTUITIVE SURGICAL, INC.
$86
Medtronic, Inc.
$24
Covidien LP
$23
Resmed Corp
$22
Inspire Medical Systems, Inc.
$20
United Therapeutics Corporation
$7
Top 3 companies account for 84.4% of all-time payments
Associated products mentioned in payments ›
AIRSENSE · ANORO · ANORO ELLIPTA · Adempas · DUPIXENT · Da Vinci Surgical System · Edge · ILLUMISITE · INSPIRE · ION · NUCALA · OPSUMIT · OPSUMIT MACITENTAN · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
20
County median income
$93,985
Nearest hospital to ZIP centroid (approximate)
PROVIDENCE ST PETER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Redman is a clinical cardiology specialist, with above-average Medicare volume (top 2% in WA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Redman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Redman performed 634 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Redman receive payments from pharmaceutical companies?
Yes. Dr. Redman received a total of $131,653 from 19 companies across 248 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Redman's costs compare to other pulmonary diseases in Olympia?
Dr. Redman's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Redman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Olympia
Browse pulmonary diseases in Olympia ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in WA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in WA
Which WA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology